08:07 AM EDT, 10/06/2025 (MT Newswires) -- Stoke Therapeutics ( STOK ) said Monday it has named Ian Smith its chief executive officer.
Smith, who has has been Stoke Therapeutics' ( STOK ) interim CEO since March, will remain a board member, the company said.
Stoke Therapeutics ( STOK ) also said that Arthur Tzianabos will return to his position as chair after serving as executive chairman while the search for a CEO was conducted.